S

SSY Group Ltd
HKEX:2005

Watchlist Manager
SSY Group Ltd
HKEX:2005
Watchlist
Price: 3.73 HKD -2.1% Market Closed
Market Cap: 11B HKD
Have any thoughts about
SSY Group Ltd?
Write Note

Relative Value

The Relative Value of one SSY Group Ltd stock under the Base Case scenario is 5.37 HKD. Compared to the current market price of 3.73 HKD, SSY Group Ltd is Undervalued by 30%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
5.37 HKD
Undervaluation 30%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
87
vs Industry
52
Median 3Y
2
Median 5Y
2.2
Industry
2.5
Forward
1.6
vs History
93
vs Industry
36
Median 3Y
11.2
Median 5Y
12.7
Industry
21.9
Forward
8
vs History
69
vs Industry
29
Median 3Y
14.8
Median 5Y
18.9
Industry
16.5
vs History
4
vs Industry
13
Median 3Y
27.9
Median 5Y
22
Industry
23.6
vs History
90
vs Industry
41
Median 3Y
1.9
Median 5Y
2.1
Industry
2.1
vs History
74
vs Industry
50
Median 3Y
2.1
Median 5Y
2.2
Industry
2.6
Forward
1.8
vs History
66
vs Industry
52
Median 3Y
3.6
Median 5Y
4
Industry
5.2
vs History
76
vs Industry
42
Median 3Y
7.7
Median 5Y
8.8
Industry
13.3
Forward
6.5
vs History
88
vs Industry
40
Median 3Y
8.9
Median 5Y
10.5
Industry
16.6
Forward
7.3
vs History
60
vs Industry
28
Median 3Y
15.7
Median 5Y
18.7
Industry
15.6
vs History
19
vs Industry
7
Median 3Y
43.5
Median 5Y
44.5
Industry
19.1
vs History
80
vs Industry
49
Median 3Y
1.3
Median 5Y
1.5
Industry
1.9

Multiples Across Competitors

Competitors Multiples
SSY Group Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
HK
SSY Group Ltd
HKEX:2005
11.1B HKD 1.7 8.1 7.2 7.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
HK
S
SSY Group Ltd
HKEX:2005
Average P/E: 29.4
8.1
32%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top